Health Systems Core

卫生系统核心

基本信息

  • 批准号:
    10443678
  • 负责人:
  • 金额:
    $ 79.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Most persons with dementia (PWD) receive care outside of institutions, meaning that the physical, emotional, and financial burdens of dementia are borne not only by patients, but their caregivers as well. The fragmented, complex US health care system exacerbates the challenge of delivering coordinated, whole-person care for PWD. Designing and testing effective, practicable, non-pharmacological interventions must take into account the heterogeneity of the health care landscape, the specific needs of this complex population, and the context in which care is delivered. Although multiple interventions designed to improve care for PWD and their caregivers have demonstrated efficacy, few have been adopted widely, and virtually none formally tested in functioning health care systems (HCS). Reflecting the many unanswered questions in optimizing care for PWD, our imperative is to close the gap between the development and testing of interventions and their later adoption in real-world HCS. Thus, to develop a robust national capability to support embedded pragmatic clinical trials (ePCT), we must leverage the combined expertise of researchers and front-line clinicians to design interventions that ensure replicability, scalability, and sustainability. We will apply this expertise as we address the unique intricacies of conducting ePCTs focused on meeting the needs of PWD and their caregivers. The Health Care Systems (HCS) Core of the proposed National Institute on Aging (NIA) Alzheimer's disease (AD)/AD-related dementia (AD/ADRD) HCS Collaboratory will engage experts from integrated delivery systems, academic medical centers, nursing home systems, home care companies and other community based providers to accomplish the following Specific Aims. Aim 1. Establish a collaborative, supportive research resource involving diverse HCS in order to support and facilitate research in the settings where PWD and their caregivers receive care; Aim 2. Develop, document, and disseminate setting-specific approaches to conducting ePCTs in PWD; Aim 3. Facilitate the conduct of rigorous pilot studies, Career Development Award (CDA) projects, and NIH-funded ePCTs in diverse care HCS targeting PWD and their caregivers. IMPACT: A successful HCS Core will partner with the other AD/ADRD Collaboratory Cores and Teams to facilitate rigorous, high-quality research studies focused on PWD and their caregivers, in which multiple health care delivery organizations participate. Combining deep expertise in ePCTs and first-hand knowledge of caring for the AD/ADRD population in a range of settings, the HCS Core will become an unparalleled national research resource to help promulgate successful HCS based interventions designed to meet the needs of PWD, caregivers, and health systems that serve them.
项目摘要 大多数痴呆症(PWD)患者在机构外接受护理,这意味着他们的身体、情感、 痴呆症的经济负担不仅由病人承担,而且由他们的照顾者承担。支离破碎的, 复杂的美国医疗保健系统加剧了提供协调的全人护理的挑战, PWD。设计和测试有效、可行的非药物干预措施必须考虑到 卫生保健景观的异质性,这一复杂人群的具体需求,以及环境 在其中提供护理。虽然多种干预措施旨在改善对PWD及其 护理人员已经证明了有效性,很少有被广泛采用,几乎没有正式测试, 健康护理系统(HCS)。反映了许多未回答的问题,在优化护理, PWD,我们的当务之急是缩小干预措施的开发和测试与其后续发展之间的差距。 在现实世界的HCS中采用。因此,要发展强有力的国家能力, 临床试验(ePCT),我们必须利用研究人员和一线临床医生的综合专业知识, 设计确保可复制性、可扩展性和可持续性的干预措施。我们将运用这些专业知识, 解决开展ePCT的独特复杂性,重点是满足残疾人及其 照顾者拟议中的国家老龄问题研究所(NIA)的卫生保健系统(HCS)核心 阿尔茨海默病(AD)/AD相关痴呆(AD/ADRD)HCS合作实验室将聘请来自 综合交付系统、学术医疗中心、疗养院系统、家庭护理公司和 其他社区为基础的供应商,以实现以下具体目标。目标1.建立一个协作, 支持性研究资源,涉及不同的HCS,以支持和促进环境中的研究 残疾人及其照顾者接受护理的地方;目标2。制定、记录和传播特定环境 在PWD中进行ePCT的方法;目标3。促进开展严格的试点研究, 发展奖(CDA)项目,以及NIH资助的针对PWD及其 照顾者影响:成功的HCS核心将与其他AD/ADRD合作实验室核心合作, 团队促进严格的,高质量的研究研究,重点是残疾人及其照顾者,其中 多个卫生保健提供组织参与。结合ePCT的深厚专业知识和第一手资料, 在一系列环境中照顾AD/ADRD人群的知识,HCS核心将成为一个 无与伦比的国家研究资源,以帮助颁布成功的基于HCS的干预措施, 满足残疾人、照顾者和为他们服务的卫生系统的需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric B Larson其他文献

Neuropathologic Burden and Dementia in Nonagenarians and Centenarians.
九十多岁和百岁老人的神经病理负担和痴呆。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    B. Cholerton;Caitlin S. Latimer;Paul K. Crane;M. Corrada;Laura E. Gibbons;Eric B Larson;Claudia H. Kawas;C. D. Keene;T. Montine
  • 通讯作者:
    T. Montine
Dementia prevention, intervention, and care: 2024 report of the emLancet/em standing Commission
痴呆症的预防、干预与照护:《柳叶刀》常设委员会2024年报告
  • DOI:
    10.1016/s0140-6736(24)01296-0
  • 发表时间:
    2024-08-10
  • 期刊:
  • 影响因子:
    88.500
  • 作者:
    Gill Livingston;Jonathan Huntley;Kathy Y Liu;Sergi G Costafreda;Geir Selbæk;Suvarna Alladi;David Ames;Sube Banerjee;Alistair Burns;Carol Brayne;Nick C Fox;Cleusa P Ferri;Laura N Gitlin;Robert Howard;Helen C Kales;Mika Kivimäki;Eric B Larson;Noeline Nakasujja;Kenneth Rockwood;Quincy Samus;Naaheed Mukadam
  • 通讯作者:
    Naaheed Mukadam
The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues
日本和非裔美国人人群中阿尔茨海默病和血管性痴呆的流行病学:寻找病因线索
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    M. Shadlen;Eric B Larson;Michi Yukawa
  • 通讯作者:
    Michi Yukawa
The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies
  • DOI:
    10.1186/1755-8794-4-13
  • 发表时间:
    2011-01-26
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Catherine A McCarty;Rex L Chisholm;Christopher G Chute;Iftikhar J Kullo;Gail P Jarvik;Eric B Larson;Rongling Li;Daniel R Masys;Marylyn D Ritchie;Dan M Roden;Jeffery P Struewing;Wendy A Wolf
  • 通讯作者:
    Wendy A Wolf

Eric B Larson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric B Larson', 18)}}的其他基金

Annual Adult Changes in Thought (ACT) symposium on aging, dementia, and Alzheimer's disease
关于衰老、痴呆和阿尔茨海默病的年度成人思想变化 (ACT) 研讨会
  • 批准号:
    10066181
  • 财政年份:
    2020
  • 资助金额:
    $ 79.36万
  • 项目类别:
Health Systems Core
卫生系统核心
  • 批准号:
    10673678
  • 财政年份:
    2019
  • 资助金额:
    $ 79.36万
  • 项目类别:
Health Systems Core
卫生系统核心
  • 批准号:
    10229433
  • 财政年份:
    2019
  • 资助金额:
    $ 79.36万
  • 项目类别:
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
多域阿尔茨海默病风险降低研究 (MARRS) 试点
  • 批准号:
    9697410
  • 财政年份:
    2017
  • 资助金额:
    $ 79.36万
  • 项目类别:
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
多域阿尔茨海默病风险降低研究 (MARRS) 试点
  • 批准号:
    9422490
  • 财政年份:
    2017
  • 资助金额:
    $ 79.36万
  • 项目类别:
The ACT annual symposium: a living, learning, national collaboratory to advance Alzheimer's disease and brain aging research
ACT 年度研讨会:一个活跃、学习、推进阿尔茨海默病和大脑衰老研究的国家合作机构
  • 批准号:
    9395822
  • 财政年份:
    2017
  • 资助金额:
    $ 79.36万
  • 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
  • 批准号:
    7902293
  • 财政年份:
    2007
  • 资助金额:
    $ 79.36万
  • 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
  • 批准号:
    7688756
  • 财政年份:
    2007
  • 资助金额:
    $ 79.36万
  • 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
  • 批准号:
    7921317
  • 财政年份:
    2007
  • 资助金额:
    $ 79.36万
  • 项目类别:
Development and Use of Network Infrastructure for High-Throughput GWA Studies
高通量 GWA 研究网络基础设施的开发和使用
  • 批准号:
    7427364
  • 财政年份:
    2007
  • 资助金额:
    $ 79.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了